Evidence map›Paper›PMID 36202131›Full record

ReviewThe lancet. Healthy longevity2022

The bullwhip effect, T-cell telomeres, and SARS-CoV-2.

Abraham Aviv

Erratum issuedOpen access · goldAbstract readReview
In one paragraph

Review in The lancet. Healthy longevity, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.8field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Abraham AvivCenter of Human Development and Aging, New Jersey Medical School, Rutgers, The State University of New Jersey, Newark, NJ, USA. Electronic address: avivab@njms.rutgers.edu.
Rutgers, The State University of New Jersey · US

Funding

Telomeres and Female FecundityR01HL134840 · NHLBI · RBHS-NEW JERSEY MEDICAL SCHOOL · PI AVIV, ABRAHAM, MAGNUS, PER · 2017 to 2020
$2.6M
Telomere Length Measurements: Strengths and LimitationsU01AG066529 · NIA · RBHS-NEW JERSEY MEDICAL SCHOOL · PI AVIV, ABRAHAM · 2019 to 2021
$911k
Shorter T-cell telomeres, lymphopenia, and high mortality of older people with COVID-19R56AG073226 · NIA · RBHS-NEW JERSEY MEDICAL SCHOOL · PI AVIV, ABRAHAM, KRAFT, BRYAN D. · 2021 to 2021
$322k
NHLBI NIH HHS R01 HL134840NIA NIH HHS R56 AG073226NIA NIH HHS U01 AG066529
6 · The paper itself

Abstract

Both myeloid cells, which contribute to innate immunity, and lymphoid cells, which dominate adaptive immunity, partake in defending against SARS-CoV-2. In response to the virus, the otherwise slow haematopoietic production supply chain quickly unleashes its preconfigured myeloid element, which largely resists a bullwhip-like effect. By contrast, the lymphoid element risks a bullwhip-like effect when it produces T cells and B cells that are specifically designed to clear the virus. As T-cell production is telomere-length dependent and telomeres shorten with age, older adults are at higher risk of a T-cell shortfall when contracting SARS-CoV-2 than are younger adults. A poorly calibrated adaptive immune response, stemming from a bullwhip-like effect, compounded by a T-cell deficit, might thus contribute to the propensity of people with inherently short T-cell telomeres to develop severe COVID-19. The immune systems of these individuals might also generate an inadequate T-cell response to anti-SARS-CoV-2 vaccination.

Indexed as

COVID-19SARS-CoV-2Adaptive ImmunityAgedHumansTelomereT-Lymphocytes

Identifiers

PMID36202131
PMCPMC9529217
OpenAlexW4300816778

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.